Skip to main content Skip to footer content

About : Next generation biotech company

tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation tissue protective therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug Tiprelestat.

5 Facts about tiakis

Located in Kiel in the north of Germany

More than 20 years of experience

Lead by a dynamic and multi-disciplinary team

Trusted by renowned partners all over the world

Selected as a partner in federal and state driven R&D programs

“Incorporated in 2000 with full focus on its novel therapy approach“

Our Values : Driven by the vision to improve human health

We seek to shift the treatment paradigm towards an early onset of treatment approach that alleviates the suffering and morbidity of most patients undergoing highly invasive surgery by protecting them from inflammatory organ damage and failure.


We aim to alleviate the suffering and morbidity of patients undergoing highly invasive surgery


We want to improve the quality of life for patients with chronic pulmonary disease such as pulmonary arterial hypertension


We employ the human body’s own and natural defense mechanisms


We want to treat underlying root causes instead of just the symptoms


More than 20 years of patient dedicated reliability towards our partners and stakeholders

For quotes regarding the sale of Elafin, please contact our sales team

Become part of the tiakis team

Find our current job offers here